| |
|
|
|
|
|
|
|||
|
HM Lorenz, AS Lagoo and KJ Hardy
Birmingham Veterans Administration Hospital.
We recently reported that cross-linking the leukocyte common antigen (CD45)
can rapidly induce aggregation of human peripheral blood mononuclear cells
via lymphocyte function-associated antigen-1 (LFA-1) and intercellular
adhesion molecule-1 (ICAM-1) interactions. Herein, we have examined both
T-cell--monocyte cellular interactions and the molecular signaling that are
involved in this phenomenon. Experiments using highly purified T
lymphocytes showed that CD45-induced aggregation requires the presence of
both T cells and monocytes. Cross- linking CD45 only on T lymphocytes, but
not on monocytes, initiated cellular clustering after reconstituting to the
respective untreated cell type. By several criteria, CD45-induced
clustering of T cells to autologous monocytes was shown to be
Fc-receptor--independent. When comparing intracellular signaling in
leukocyte aggregation induced by CD45 cross-linking versus phorbol
myristate-12-13-acetate (PMA) treatment, the former was found to be
fivefold to 10-fold more sensitive to H-8, a reagent that effectively
blocks cAMP- and cGMP- dependent protein kinases. On the other hand,
reagents that increase intracellular cAMP levels (eg, dbcAMP, forskolin,
and IBMX), protein kinase C (PKC) inhibitors (eg, staurosporine), and
tyrosine kinase inhibitors (eg, herbimycin A and genistein) all readily
inhibited PMA- induced, but not CD45 monoclonal antibody-induced,
aggregation. We conclude that cross-linking the leukocyte common antigen on
T cells induces LFA-1--/ICAM-1--dependent T-cell--monocyte aggregation
through a unique signaling pathway independent of PKC, which involves
instead cAMP-/cGMP-dependent protein kinases.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1994 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||